WB
Western blot analysis of lysates from COS7 cells treated with TSA 400uM 24h, using Lys-Acetylated Proteins Antibody. The lane on the right is blocked with the synthesized peptide.IHC
Immunohistochemistry analysis of paraffin-embedded human lung carcinoma, using Lys-Acetylated Proteins Antibody. The picture on the right is blocked with the synthesized peptide.ICC/IF
Immunofluorescence analysis of HeLa cells, using Lys-Acetylated Proteins Antibody. The picture on the right is blocked with the synthesized peptide.| Product Name | Acetyl Lys proteins Polyclonal Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Acetylation of lysine, like phosphorylation of serine, threonine or tyrosine, is an important reversible modification controlling protein activity. The conserved amino-terminal domains of the four core histones (H2A, H2B, H3, and H4) contain lysines that are acetylated by histone acetyltransferases (HATs) and deacetylated by histone deacetylases (HDACs). Signaling resulting in acetylation/deacetylation of histones, transcription factors, and other proteins affects a diverse array of cellular processes including chromatin structure and gene activity, cell growth, differentiation, and apoptosis. Recent proteomic surveys suggest that acetylation of lysine residues may be a widespread and important form of posttranslational protein modification that affects thousands of proteins involved in control of cell cycle and metabolism, longevity, actin polymerization, and nuclear transport. The regulation of protein acetylation status is impaired in cancer and polyglutamine diseases, and HDACs have become promising targets for anti-cancer drugs currently in development. |
| Immunogen | Synthesized acetyl-peptide derived from human acetylation Lys proteins. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | ELISAICC/IFIHCWB |
| WB:1:500-1:2000 IHC:1:100-1:300 ICC:1:200-1:1000 |
|
| Species Reactivity | HumanMonkeyMousePlantRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Molecular Weight(MW) | 20,40,80,175kD |
|---|
WB
Western blot analysis of lysates from COS7 cells treated with TSA 400uM 24h, using Lys-Acetylated Proteins Antibody. The lane on the right is blocked with the synthesized peptide.
IHC
Immunohistochemistry analysis of paraffin-embedded human lung carcinoma, using Lys-Acetylated Proteins Antibody. The picture on the right is blocked with the synthesized peptide.
ICC/IF
Immunofluorescence analysis of HeLa cells, using Lys-Acetylated Proteins Antibody. The picture on the right is blocked with the synthesized peptide.| Application Notes | WB:1:500-1:2000 IHC:1:100-1:300 ICC:1:200-1:1000 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | -15°C to -25°C/1 year(Do not lower than -25°C) |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
